Altus Pharmaceuticals Inc. S-1
Accession 0000950135-05-005771
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 14, 5:40 PM ET
Size
3.1 MB
Accession
0000950135-05-005771
Documents
- S-1b57089apsv1.htmPrimary
ALTUS PHARMACEUTICALS INC.
- EX-3.1b57089apexv3w1.txt
EX-3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
- EX-3.3b57089apexv3w3.txt
EX-3.3 SECOND AMENDED AND RESTATED BY-LAWS
- EX-4.2b57089apexv4w2.txt
EX-4.2 AMENDED AND RESTATED STOCKHOLDER VOTING AGREEMENT
- EX-4.3b57089apexv4w3.txt
EX-4.3 AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
- EX-4.4b57089apexv4w4.txt
EX-4.4 AMENDED AND RESTATED RIGHTS OF FIRST REFUSAL
- EX-4.5b57089apexv4w5.txt
EX-4.5 AMENDED AND RESTATED VOTING STANDSTILL AGREEMENT
- EX-4.6b57089apexv4w6.txt
EX-4.6 FORM OF COMMON STOCK WARRANT TO VERTEX PHARMACEUTICALS
- EX-4.7b57089apexv4w7.txt
EX-4.7 FORM OF COMMON STOCK WARRANT TO GENERAL ELECTRIC CAPITAL CORP.
- EX-4.8b57089apexv4w8.txt
EX-4.8 FORM OF COMMON STOCK WARRANT TO OXFORD FINANCE CORP.
- EX-4.9b57089apexv4w9.txt
EX-4.9 FORM OF COMMON STOCK WARRANT TO CYSTIC FIBROSIS FOUNDATION
- EX-4.10b57089apexv4w10.txt
EX-4.10 FORM OF COMMON STOCK WARRANT TO TRANSAMERICA BUSINESS CREDIT CORP.
- EX-4.11b57089apexv4w11.txt
EX-4.11 FORM OF COMMON STOCK WARRANT TO SG COWEN & COMPANY
- EX-4.12b57089apexv4w12.txt
EX-4.12 FORM OF SERIES B PREFERRED STOCK WARRANT
- EX-4.13b57089apexv4w13.txt
EX-4.13 FORM OF SERIES C PREFERRED STOCK WARRANT
- EX-10.1b57089apexv10w1.txt
EX-10.1 1993 STOCK OPTION PLAN
- EX-10.2b57089apexv10w2.txt
EX-10.2 FORM OF INCENTIVE STOCK OPTION PLAN
- EX-10.3b57089apexv10w3.txt
EX-10.3 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT
- EX-10.5b57089apexv10w5.txt
EX-10.5 FORM OF INCENTIVE STOCK OPTION AGREEMENT
- EX-10.6b57089apexv10w6.txt
EX-10.6 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT
- EX-10.8b57089apexv10w8.txt
EX-10.8 MASTER LEASE AGREEMENT - GENERAL ELECTRIC CAPITAL CORP.
- EX-10.9b57089apexv10w9.txt
EX-10.9 MASTER LOAN AGREEMENT OXFORD FINANCE
- EX-10.10b57089apexv10w10.txt
EX-10.10 FORM OF PROMISSORY NOTE OXFORD FINANCE
- EX-10.11b57089apexv10w11.txt
EX-10.11 MASTER SECURITY AGREEMENT OXFORD FINANCE
- EX-10.12b57089apexv10w12.txt
EX-10.12 FORM OF PROMISSORY NOTE OXFORD FINANCE
- EX-10.18b57089apexv10w18.txt
EX-10.18 SEPARATION AGREEMENT - PETER LANCIANO
- EX-10.19b57089apexv10w19.txt
EX-10.19 CONSULTING AGREEMENT - MANUEL A. NAVIA
- EX-10.20b57089apexv10w20.txt
EX-10.20 DESCRIPTION OF ARRANGEMENT - JOHN P. RICHARD
- EX-10.21b57089apexv10w21.txt
EX-10.21 LEASE AGREEMENT RIZIKA REALTY TRUST
- EX-10.22b57089apexv10w22.txt
EX-10.22 LEASE AGREEMENT FORT WASHINGTON REALTY
- EX-10.23b57089apexv10w23.txt
EX-10.23 DESCRIPTION OF EXECUTIVE OFFICER RETENTION ARRANGEMENT
- EX-10.24b57089apexv10w24.txt
EX-10.24 SUBLEASE AGREEMENT VERTEX PHARMACEUTICALS
- EX-10.25b57089apexv10w25.txt
EX-10.25 SUBLEASE AGREEMENT TRANSKARYOTIC PHARMACEUTICALS
- EX-21b57089apexv21.txt
EX-21 SUBSIDIARIES OF THE REGISTRANT
- EX-23.1b57089apexv23w1.txt
EX-23.1 CONSENT OF DELOUTTE & TOUCHE LLP
- GRAPHICb57089apb5708900.gif
GRAPHIC
- GRAPHICb57089apb5708901.gif
GRAPHIC
- COVERfilename39.htm
Issuer
Altus Pharmaceuticals Inc.
CIK 0001340744
Related Parties
1- filerCIK 0001340744
Filing Metadata
- Form type
- S-1
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 14, 5:40 PM ET
- Size
- 3.1 MB